Harbour Investments’s Zevra Therapeutics ZVRA Stock Holding History

Harbour Investments’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-168	Closed	-$1.1K	–	3323
2023 Q4	$1.1K	Hold	168	–	–	﹤0.01%	2805
2023 Q3	$810	Hold	168	–	–	﹤0.01%	2737
2023 Q2	$857	Hold	168	–	–	﹤0.01%	2720
2023 Q1	$924	Hold	168	–	–	﹤0.01%	2702
2022 Q4	$771	Hold	168	–	–	﹤0.01%	2731
2022 Q3	$1K	Hold	168	–	–	﹤0.01%	2680
2022 Q2	$1K	Buy	+168	New	+$766	﹤0.01%	2680
2021 Q4	$1K	Hold	168	–	–	﹤0.01%	2577
2021 Q3	$2K	Hold	168	–	–	﹤0.01%	3386
2021 Q2	$2K	Hold	168	–	–	﹤0.01%	3448
2021 Q1	$2K	Buy	+168	New	+$1.47K	﹤0.01%	3286

Other funds holding ZVRA

Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janney Montgomery Scott

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return

Altium Capital Management New York $42M AUM